Xgeva
Xgeva | |
---|---|
Term | Xgeva |
Short definition | Xgeva - (pronounced) (ex-JEE-vuh) drug that contains the active ingredient denosumab and is used to prevent or treat certain bone problems. Xgeva is used to prevent bone problems caused by multiple myeloma, or solid tumors that have spread to the bone. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Xgeva - (pronounced) (ex-JEE-vuh) drug that contains the active ingredient denosumab and is used to prevent or treat certain bone problems. Xgeva is used to prevent bone problems caused by multiple myeloma, or solid tumors that have spread to the bone. It is also used in certain patients to treat giant cell tumors of the bone that cannot be surgically removed and to treat hypercalcaemia related to cancer that has not improved after treatment with bisphosphonates. Xgeva attaches to a protein called RANKL, which prevents RANKL from attaching to another protein called RANK on the surface of certain bone cells, including bone cancer cells. This can help prevent bone loss and cancer cell growth. Xgeva can also prevent the loss of calcium from the bones. It's a type of monoclonal antibody
External links
- Medical encyclopedia article on Xgeva
- Wikipedia's article - Xgeva
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski